Can-Fite BioPharma Ltd. (CANF)
AMEX·Healthcare·Biotechnology
$3.27
+3.48%
Mkt Cap $2.20M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+52.9%
Consensus $5.00 vs current $3.27
AMEX·Healthcare·Biotechnology
$3.27
+3.48%
Mkt Cap $2.20M
No recent rating data.
Price Target (3 analysts)
$5.00
Range $5.00 – $5.00
+52.9%
Consensus $5.00 vs current $3.27